HASS Development method: Screen development, change schedule, and re-prove schedule

被引:3
|
作者
Silverman, M [1 ]
机构
[1] QualMark Corp, Santa Clara, CA 95050 USA
关键词
Highly Accelerated Life Test (HALT); Highly Accelerated Stress Screen (HASS); HASS Development; Highly Accelerated Stress Audit (HASA); Failure Modes and Effects Analysis (FMEA);
D O I
10.1109/RAMS.2000.816315
中图分类号
TP31 [计算机软件];
学科分类号
081202 ; 0835 ;
摘要
HALT and HASS are two very powerful tools that can help manufacturers achieve high reliability quickly both in the design phase and in the manufacturing phase. HALT is used in the design phase to help reduce the number of design-related problems. HASS is used in the production phase to help reduce the number of infant mortality types of failures. HALT is always performed prior to developing a HASS profile because the HASS profile uses the information from HALT when choosing the profile parameters. Screens for HASS are always developed using a HASS Development process. The goal of HASS Development is to provide the most effective and quickest screen possible The effectiveness of the screen is measured in its ability to find defects in the product without removing significant life. This paper describes different methods of developing a screen using the HASS Development methodology and gives guidelines on when to change a screen and when it is necessary to re-submit a product through the HASS Development process in order to reprove a screen.
引用
收藏
页码:245 / 247
页数:3
相关论文
共 50 条
  • [21] Individual development schedule: A case of dyslexia.
    Benavente, IM
    GonzalezGonzalez, S
    PSICOTHEMA, 1996, 8 (03) : 507 - 511
  • [22] CONDENSED SCHEDULE FOR ENERGY-RESOURCE DEVELOPMENT
    PENNER, SS
    ANNALS OF NUCLEAR SCIENCE AND ENGINEERING, 1974, 1 (05): : 339 - 341
  • [23] A Critical Design Structure Method for Project Schedule Development under Rework Risks
    Ma, Guofeng
    Jia, Jianyao
    Zhu, Tiancheng
    Jiang, Shan
    SUSTAINABILITY, 2019, 11 (24)
  • [24] Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule
    Nadja E. Schoemaker
    Ron A. Mathôt
    Patrick Schöffski
    Hilde Rosing
    Jan H. Schellens
    Jos H. Beijnen
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 514 - 517
  • [25] Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule
    Schoemaker, NE
    Mathôt, RAA
    Schöffski, P
    Rosing, H
    Schellens, JHM
    Beijnen, JH
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (06) : 514 - 517
  • [26] Development of a classroom observation schedule for measuring the efficacy of a teacher development programme
    Rizvi, Meher
    INNOVATION AND CREATIVITY IN EDUCATION, 2010, 2 (02): : 654 - 660
  • [27] SCHEDULE OF SOCIAL-ECONOMICAL DEVELOPMENT OF COUNTRY IN 1973
    不详
    MECHANIK MIESIECZNIK NAUKOWO-TECHNICZNY, 1973, 46 (01): : 1 - 1
  • [28] Development and evaluation of HVAC operation schedule detection algorithm
    Kim, Woohyun
    Katipamula, Srinivas
    Lutes, Robert
    ENERGY AND BUILDINGS, 2019, 202
  • [29] Development of an International Schedule for the Assessment and Staging of Care for Dementia
    Semrau, Maya
    Burns, Alistair
    Djukic-Dejanovic, Slavica
    Eraslan, Defne
    Han, Changsu
    Lecic-Tosevski, Dusica
    Lobo, Antonio
    Mihai, Adriana
    Morris, Julie
    Palumbo, Claudia
    Robert, Philippe
    Stiens, Gerthild
    Stoppe, Gabriela
    Volpe, Umberto
    Rikkert, Marcel Olde
    Sartorius, Norman
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 44 (01) : 139 - 151
  • [30] Development of quantitative cost and schedule risk analysis process
    Moses, KD
    Hooker, SF
    18th International Conference on Systems Engineering, Proceedings, 2005, : 382 - 387